These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 20044455)

  • 21. Pulmonary artery hypertension as the presenting feature of systemic sclerosis sine scleroderma.
    Pauling JD; Gunawardena H; Coghlan JG; Easaw J; Suntharalingam J; McHugh NJ
    Rheumatology (Oxford); 2008 Sep; 47(9):1431-2. PubMed ID: 18603658
    [No Abstract]   [Full Text] [Related]  

  • 22. Latent pulmonary inflammation in patients with systemic sclerosis.
    Sánchez-Vidaurre S; Simeón CP; Cruz MJ; Fonollosa V; Vilardell M; Morell F; Muñoz X
    Arch Bronconeumol; 2012 Jan; 48(1):8-13. PubMed ID: 22133713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pulmonary involvement in progressive systemic sclerosis].
    Grisanti M; Vicencio M
    Rev Med Chil; 1986 Oct; 114(10):1002-5. PubMed ID: 3575934
    [No Abstract]   [Full Text] [Related]  

  • 24. [An up date on pulmonary hypertension related to systemic sclerosis].
    Kowal-Bielecka O; Sulik A; Sierakowski S
    Przegl Lek; 2005; 62(8):813-7. PubMed ID: 16521504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is exercise-induced pulmonary hypertension ready for prime time in systemic sclerosis?
    Steen VD; Champion H
    Int J Clin Pract Suppl; 2011 Jan; (169):1-3. PubMed ID: 21176008
    [No Abstract]   [Full Text] [Related]  

  • 26. Assessment and management of scleroderma lung disease.
    Bolster MB; Silver RM
    Curr Opin Rheumatol; 1999 Nov; 11(6):508-13. PubMed ID: 10551676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac complications of systemic sclerosis: recent progress in diagnosis.
    Boueiz A; Mathai SC; Hummers LK; Hassoun PM
    Curr Opin Rheumatol; 2010 Nov; 22(6):696-703. PubMed ID: 20657283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pulmonary arterial hypertension in collagen disease: experiences of the German Network for Systemic Scleroderma].
    Hunzelmann N; Riemekasten G
    Dtsch Med Wochenschr; 2006 Dec; 131(49 Suppl 9):S325-7. PubMed ID: 17139598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A possible contribution of elevated serum clusterin levels to the inhibition of digital ulcers and pulmonary arterial hypertension in systemic sclerosis.
    Yanaba K; Asano Y; Tada Y; Sugaya M; Kadono T; Sato S
    Arch Dermatol Res; 2012 Aug; 304(6):459-63. PubMed ID: 22350181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transient effect of nifedipine on pulmonary hypertension of systemic sclerosis.
    Fudman EJ; Kelling DG
    J Rheumatol; 1985 Dec; 12(6):1191-2. PubMed ID: 4093929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IgG from patients with pulmonary arterial hypertension and/or systemic sclerosis binds to vascular smooth muscle cells and induces cell contraction.
    Bussone G; Tamby MC; Calzas C; Kherbeck N; Sahbatou Y; Sanson C; Ghazal K; Dib H; Weksler BB; Broussard C; Verrecchia F; Yaici A; Witko-Sarsat V; Simonneau G; Guillevin L; Humbert M; Mouthon L
    Ann Rheum Dis; 2012 Apr; 71(4):596-605. PubMed ID: 22084393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mortality in systemic sclerosis (scleroderma).
    Lee P; Langevitz P; Alderdice CA; Aubrey M; Baer PA; Baron M; Buskila D; Dutz JP; Khostanteen I; Piper S
    Q J Med; 1992 Feb; 82(298):139-48. PubMed ID: 1620814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is pulmonary arterial hypertension really a late complication of systemic sclerosis?
    Campo A; Mathai SC; Girgis RE; Hassoun PM
    Chest; 2010 Aug; 138(2):461-2; author reply 462-3. PubMed ID: 20682545
    [No Abstract]   [Full Text] [Related]  

  • 34. Pulmonary arterial hypertension and severe pulmonary fibrosis in systemic sclerosis patients with a nucleolar antibody.
    Steen VD; Lucas M; Fertig N; Medsger TA
    J Rheumatol; 2007 Nov; 34(11):2230-5. PubMed ID: 17937469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cardiac repercussions in the CREST syndrome].
    Cardama JE; Gatti JC; Olivares LM; Pizzariello GE; Lebek AP; Romorini A
    Med Cutan Ibero Lat Am; 1987; 15(4):265-73. PubMed ID: 2961963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Survival of patients with pulmonary arterial hypertension, associated with systemic sclerosis].
    Ter Arkh; 2012; 84(5):24-8. PubMed ID: 22830207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for pulmonary arterial hypertension in systemic sclerosis.
    Busteed S; Moots RJ; Thompson RN
    Rheumatology (Oxford); 2004 Oct; 43(10):1315-6; author reply 1316. PubMed ID: 15448224
    [No Abstract]   [Full Text] [Related]  

  • 38. [Cardiac and pulmonary involvement in scleroderma].
    Launay D; Hachulla E
    Rev Prat; 2002 Nov; 52(17):1901-7. PubMed ID: 12532867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of pulmonary arterial hypertension due to scleroderma: challenges for the future.
    Rubin LJ
    Rheum Dis Clin North Am; 2008 Feb; 34(1):191-7; viii. PubMed ID: 18329540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nailfold capillary density is associated with the presence and severity of pulmonary arterial hypertension in systemic sclerosis.
    Hofstee HM; Vonk Noordegraaf A; Voskuyl AE; Dijkmans BA; Postmus PE; Smulders YM; Serné EH
    Ann Rheum Dis; 2009 Feb; 68(2):191-5. PubMed ID: 18375538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.